Story perspectives

FDA Cracks Down on Telehealth Weight Loss Drug Claims

3/13/2026

Summary

Story summary

The Food and Drug Administration (FDA) is increasing scrutiny on telehealth companies marketing compounded weight loss drugs and cautioned them not to claim FDA approval or manufacturing.
Companies such as Lovely Meds and Hello Cake do not directly prescribe these unapproved medications.
An analysis found that over 30% of more than 70 warned telehealth companies are linked to four medical groups: Beluga Health, OpenLoop, MD Integrations, Telegra, underscoring the crackdown.

1 of 1

Story summary

The Food and Drug Administration (FDA) is increasing scrutiny on telehealth companies marketing compounded weight loss drugs and cautioned them not to claim FDA approval or manufacturing.
Companies such as Lovely Meds and Hello Cake do not directly prescribe these unapproved medications.
An analysis found that over 30% of more than 70 warned telehealth companies are linked to four medical groups: Beluga Health, OpenLoop, MD Integrations, Telegra, underscoring the crackdown.